Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	6.37	10.72	29.47	19.38	9.95
Short-Term Investments	-	52.86	2.41	1.51	1.08	1.09
Trading Asset Securities	-	-	8.08	3.08	0.58	0.58
Cash & Short-Term Investments	87.29	59.23	21.21	34.05	21.04	11.62
Cash Growth	404.51%	179.31%	-37.73%	61.84%	81.16%	-62.41%
Accounts Receivable	-	1,771	648.49	345.6	902.73	410.75
Other Receivables	-	-	-	-	0.16	0.18
Receivables	-	1,776	650.95	347.11	903.79	418.19
Inventory	-	2,399	1,750	1,501	464.6	675.75
Restricted Cash	-	0.5	0.38	3.38	0.26	0.25
Other Current Assets	-	45.02	149.49	276.34	136.81	195.01
Total Current Assets	-	4,280	2,572	2,162	1,526	1,301
Property, Plant & Equipment	-	524.89	461.53	386.26	322.82	303.25
Long-Term Investments	-	12.43	4.66	0.03	0.03	0.03
Other Intangible Assets	-	4.27	4.2	3.08	0.56	0.27
Other Long-Term Assets	-	52.98	33.61	21.32	19.98	11.83
Total Assets	-	4,874	3,076	2,573	1,870	1,616
Accounts Payable	-	1,448	629.47	593.43	486.17	599.61
Accrued Expenses	-	60.62	27.98	27.47	24.45	20.53
Short-Term Debt	-	1,506	867.6	677.09	186.19	167.37
Current Portion of Long-Term Debt	-	69.21	59.52	33.98	-	-
Current Portion of Leases	-	12.37	-	-	-	-
Current Income Taxes Payable	-	71.16	55.35	42.9	27.91	11.26
Other Current Liabilities	-	113.84	28.36	21.7	12.79	65.8
Total Current Liabilities	-	3,281	1,668	1,397	737.5	864.56
Long-Term Debt	-	96.13	127.98	154.4	420.39	291.11
Pension & Post-Retirement Benefits	-	18.56	11.62	9.97	10.03	10.01
Long-Term Deferred Tax Liabilities	-	44.84	41.37	38.43	14.31	13.77
Other Long-Term Liabilities	-	19.77	12.04	9.67	7.05	6.04
Total Liabilities	-	3,460	1,861	1,609	1,189	1,185
Common Stock	-	47.22	46.99	45.32	44.33	39.9
Additional Paid-In Capital	-	738.23	714.27	549.69	454.12	271.55
Retained Earnings	-	628.39	437.73	285.48	180.04	119.26
Comprehensive Income & Other	-	-0	15.72	83.27	2.13	-
Total Common Equity	1,572	1,414	1,215	963.76	680.61	430.7
Shareholders' Equity	1,572	1,414	1,215	963.76	680.61	430.7
Total Liabilities & Equity	-	4,874	3,076	2,573	1,870	1,616
Total Debt	1,710	1,684	1,055	865.47	606.59	458.48
Net Cash (Debt)	-1,623	-1,625	-1,034	-831.41	-585.54	-446.87
Net Cash Per Share	-349.70	-349.98	-222.73	-185.67	-141.03	-112.00
Filing Date Shares Outstanding	4.72	4.72	4.7	4.53	4.43	3.99
Total Common Shares Outstanding	4.72	4.72	4.7	4.53	4.43	3.99
Working Capital	-	998.56	903.72	765.54	788.99	436.25
Book Value Per Share	333.11	299.43	258.50	212.64	153.54	107.96
Tangible Book Value	1,568	1,410	1,211	960.68	680.05	430.43
Tangible Book Value Per Share	332.18	298.53	257.60	211.96	153.42	107.89
Land	-	5.24	5.24	5.24	5.24	5.24
Buildings	-	235.73	220.93	210.02	210.02	200.76
Machinery	-	547.57	391.07	289.59	198.63	167.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.